Stockreport

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures [Yahoo! Finance]

InspireMD Inc.  (NSPR) 
NASDAQ:AMEX Investor Relations: inspiremd.com/en/investors/investor-relations
PDF InspireMD, Inc. Thu, February 13, 2025 at 1:00 PM GMT+1 3 min read In This Article NSPR InspireMD, Inc. TOLEDO, Ohio and MIAMI, Feb. 13, 2025 (GLOBE NEWSWIR [Read more]